Skip to main content
John Heesakkers

John Heesakkers

🇳🇱 Netherlands

Training and career​

  • Current position Professor, Maastricht University; head, Department of Urology, Maastricht UMC1
  • Medical school Medicine, Radboud University of Nijmegen1
  • Other training Urology training, University Hospital Maastricht (began 1993)1
  • Leadership General secretary, International Continence Society (2022–2025)1

Contributions​

His cited work covers sacral and tibial neuromodulation for lower urinary tract dysfunction and urgency urinary incontinence, including implantable tibial stimulation and follow-up from the OASIS study.23456

  • Clinical study of implantable tibial nerve neuromodulation (2018). Led a clinical study evaluating a leadless implantable tibial nerve stimulation system for overactive bladder symptoms.7 Cited on WARWIKI: Implantable Tibial Nerve Stimulation (iTNM).

Cited on WARWIKI

14 publications with John Heesakkers as a listed author are cited on WARWIKI, ordered by the number of pages that cite them. Papers whose author list is shortened to "et al." before this name are not included.

  1. Tutolo M, Ammirati E, Heesakkers J, et al. "Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-Neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature." Eur Urol. 2018;73(3):406-418. doi
    Cited on: Percutaneous Tibial Nerve Stimulation · Sacral Neuromodulation · Geriatric Urogynecology & Reconstructive Urology
  2. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Outcomes of a Prospective, Worldwide Clinical Study. The Journal of Urology. 2007;178(5):2029-2034. doi
    Cited on: Medtronic InterStim — Sacral Neuromodulation · Percutaneous Nerve Evaluation · Sacral Neuromodulation
  3. Amundsen CL, Sutherland SE, Heesakkers JPFA, et al. Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation From the Pivotal OASIS Study. The Journal of Urology. 2026;216(2):219-229. doi
    Cited on: Revi — Implantable Tibial Neuromodulation · Implantable Tibial Nerve Stimulation (iTNM)
  4. Sutherland SE, Heesakkers JPFA, Ferrante KL, Dmochowski RR. Impact of Revi Implantable Tibial Neuromodulation on Quality of Life in Patients With Urgency Urinary Incontinence. International Urogynecology Journal. 2026;37(8):2451-2461. doi
    Cited on: Revi — Implantable Tibial Neuromodulation · Implantable Tibial Nerve Stimulation (iTNM)
  5. Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, et al. Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinence. The Journal of Urology. 2025;213(3):323-332. doi
    Cited on: Revi — Implantable Tibial Neuromodulation · Implantable Tibial Nerve Stimulation (iTNM)
  6. van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. The Journal of Urology. 2017;198(1):205-210. doi
    Cited on: Revi — Implantable Tibial Neuromodulation · Implantable Tibial Nerve Stimulation (iTNM)
  7. Moris L, Heesakkers J, Nitti V, et al. Prevalence, diagnosis, and management of stress urinary incontinence in women: a collaborative review. Eur Urol. 2025;87(3):292–301. PMID 39848866.
    Cited on: Stress Urinary Incontinence (Female)
  8. Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, et al. A Prospective Study to Assess the Effectiveness and Safety of the BlueWind System in the Treatment of Patients Diagnosed With Urgency Urinary Incontinence. Neurourology and Urodynamics. 2024;43(7):1491-1503. doi
    Cited on: Revi — Implantable Tibial Neuromodulation
  9. Te Dorsthorst MJ, Heesakkers JPFA, van Balken MR. "Long-Term Real-Life Adherence of Percutaneous Tibial Nerve Stimulation in Over 400 Patients." Neurourol Urodyn. 2020;39(2):702-706. doi
    Cited on: Implantable Tibial Nerve Stimulation (iTNM)
  10. de Vries AM, Venema PL, Heesakkers JPFA. "Midurethral Support Is Also Necessary for Reflex Closure of the Urethra." Neurourol Urodyn. 2018;37(8):2965–2972. doi
    Cited on: Female Urethra
  11. Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S. "A Novel Leadless, Miniature Implantable Tibial Nerve Neuromodulation System for the Management of Overactive Bladder Complaints." Neurourol Urodyn. 2018;37(3):1060-1067. doi
    Cited on: Implantable Tibial Nerve Stimulation (iTNM)
  12. Martens FMJ, Heesakkers J. Sacral Dorsal Rhizotomy and Sacral Anterior Root Stimulation in Neurogenic Patients: The Brindley Procedure. In: Dmochowski R, Heesakkers J, eds. Neuro-Urology. 1st ed. Springer; 2018:421-433.
    Cited on: Spinal Cord Injury

Footnotes​

  1. ICS. Dr John PFA Heesakkers. Accessed October 2026. ↩ ↩2 ↩3 ↩4

  2. van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Outcomes of a Prospective, Worldwide Clinical Study. The Journal of Urology. 2007;178(5):2029-2034. doi:10.1016/j.juro.2007.07.032 ↩

  3. Tutolo M, Ammirati E, Heesakkers J, et al. "Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-Neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature." Eur Urol. 2018;73(3):406-418. doi:10.1016/j.eururo.2017.11.002 ↩

  4. Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, et al. Two-Year Efficacy and Safety Outcomes of the Pivotal OASIS Study Using the Revi System for Treatment of Urgency Urinary Incontinence. The Journal of Urology. 2025;213(3):323-332. doi:10.1097/ju.0000000000004328 ↩

  5. Amundsen CL, Sutherland SE, Heesakkers JPFA, et al. Three-Year Efficacy and Safety of Revi Implantable Tibial Neuromodulation From the Pivotal OASIS Study. The Journal of Urology. 2026;216(2):219-229. doi:10.1097/ju.0000000000005062 ↩

  6. van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. The Journal of Urology. 2017;198(1):205-210. doi:10.1016/j.juro.2017.01.078 ↩

  7. Heesakkers JPFA, Digesu GA, van Breda J, et al. "A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints." Neurourology and Urodynamics. 2017;37(3):1060–1067. doi:10.1002/nau.23401 ↩